Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Hepatology. 2020 Apr 27;72(2):441–453. doi: 10.1002/hep.31046

Fig. 4. Clinical parameters at day 0, 28 and 42 of follow-up.

Fig. 4.

Improvement in (A) Δ total bilirubin, (B) C-reactive protein, (C) ALT, and (D) AST from the entire cohort at days 0, 28 and 42.